Health & Wellbeing

Canine Soft Tissue Sarcoma: Symptoms, Diagnosis & Treatment Guide

Learn about canine soft tissue sarcoma in dogs — symptoms, diagnosis, treatment options, costs, prognosis, and what to expect from your veterinary oncologist.

By Beth Carrasco · Published 8 September 2026
Canine Soft Tissue Sarcoma: Symptoms, Diagnosis & Treatment Guide

Canine soft tissue sarcoma (STS) is a broad category of malignant tumors that arise from connective tissues — including fat, muscle, nerves, fibrous tissue, and blood vessels — beneath or within the skin. These tumors account for approximately 8% to 15% of all skin and subcutaneous tumors in dogs, according to the Merck Veterinary Manual. Unlike some cancers that spread aggressively and early, most soft tissue sarcomas are locally invasive, meaning they push into surrounding tissue but have a relatively low to moderate rate of metastasis (spreading to distant organs). That distinction matters enormously for prognosis and treatment planning.

Soft tissue sarcomas are not a single disease but rather an umbrella term covering several tumor subtypes, including fibrosarcoma, peripheral nerve sheath tumor, hemangiopericytoma, liposarcoma, myxosarcoma, and undifferentiated sarcoma. Each subtype behaves slightly differently, but they share enough clinical characteristics that veterinarians often group them together for treatment purposes.

If you've noticed a lump on your dog that feels firm, fixed to underlying tissue, or has been slowly growing over weeks to months, this guide will help you understand what your veterinarian may be evaluating and what to expect next. Always consult your veterinarian for an accurate diagnosis — no online resource replaces a hands-on examination and biopsy.

What Are the Symptoms of Canine Soft Tissue Sarcoma?

Soft tissue sarcomas are notoriously deceptive. They often present as a seemingly harmless lump that an owner may dismiss as a fatty deposit (lipoma) or a bug bite. Early detection significantly improves treatment outcomes, so knowing what to watch for is essential.

Canine Soft Tissue Sarcoma Symptom Checklist by Severity
Severity LevelSymptomsTypical Timeline
Early Warning Signs
  • Firm, rubbery lump beneath the skin (often 1–5 cm)
  • Lump feels fixed or attached to deeper tissue (does not move freely)
  • Slow, steady growth over weeks to months
  • Typically painless at this stage
  • Most common on limbs, chest, or abdominal wall
Present for 2–12 weeks before owner notices
Intermediate Signs
  • Tumor grows beyond 5 cm in diameter
  • Skin over tumor may become discolored, taut, or warm
  • Mild lameness if tumor is on a limb
  • Occasional licking or attention to the area by the dog
  • Tumor may feel irregular or lobulated on palpation
3–9 months of tumor growth
Advanced Symptoms
  • Ulceration or open wound on tumor surface
  • Bleeding or discharge from the mass
  • Significant pain or reluctance to be touched near the area
  • Pronounced lameness or inability to use affected limb
  • Weight loss, lethargy, decreased appetite
  • Difficulty breathing (if metastasis to lungs has occurred)
  • Neurological signs if tumor compresses a nerve (limb weakness, muscle atrophy)
6+ months; metastasis typically detected 6–18 months after initial presentation in aggressive cases
Key distinction from lipomas: Benign fatty tumors (lipomas) are typically soft, freely movable under the skin, and grow very slowly. Soft tissue sarcomas tend to feel firmer, are often anchored to underlying structures, and may grow more steadily. However, even experienced veterinarians cannot reliably distinguish between the two by palpation alone — fine needle aspiration (FNA) or biopsy is necessary.

Which Dogs Are Most at Risk? Breed Predispositions & Risk Factors

Risk Factors at a Glance
  • Age: Most common in middle-aged to older dogs (median age 8–11 years); rare in dogs under 4
  • Breed: Higher incidence in large and giant breeds — Golden Retrievers, Labrador Retrievers, German Shepherds, Boxers, and mixed-breed dogs over 40 lb (18 kg)
  • Size: Dogs over 40 lb (18 kg) are disproportionately affected
  • Sex: No strong sex predilection; some subtypes show slight male bias
  • Genetics: No single gene identified, but hereditary cancer syndromes in certain breed lines may increase risk
  • Environment: No definitive environmental cause established, though prior radiation exposure and chronic inflammation are suspected contributing factors in some cases

While soft tissue sarcomas can develop in any dog, the American Kennel Club notes that certain breeds carry elevated cancer risk broadly. Golden Retrievers and Flat-Coated Retrievers are overrepresented in sarcoma studies. However, because STS encompasses so many subtypes, breed-specific data is less precise than for cancers like hemangiosarcoma or osteosarcoma.

Mixed-breed dogs are not immune. In fact, because soft tissue sarcomas are relatively common across the general dog population, any dog presenting with a firm, growing subcutaneous mass warrants investigation regardless of breed.

How Is Canine Soft Tissue Sarcoma Diagnosed?

Diagnosis follows a structured process that moves from initial screening to definitive identification and staging. Here's what to expect during your veterinary visits:

  1. Physical Examination & History (Visit 1): Your veterinarian will palpate the mass — noting size, shape, consistency, mobility, and whether it's attached to deeper structures. They'll check regional lymph nodes and assess your dog's overall body condition. Expect to spend 30–45 minutes. Cost: $60–$120 exam fee.
  2. Fine Needle Aspiration — FNA (Visit 1 or 2): A thin needle extracts cells from the mass for cytology. FNA can often identify sarcomas, but because these tumors shed cells poorly compared to round cell tumors (like mast cell tumors), results may be inconclusive. Diagnostic accuracy of FNA for STS: approximately 60–75%. Cost: $80–$200 including cytology lab fees.
  3. Surgical Biopsy or Incisional Biopsy (Visit 2): If FNA is inconclusive, a tissue sample is obtained via punch biopsy, incisional biopsy, or sometimes excisional biopsy (removing the entire mass). The sample goes to a veterinary pathologist for histopathology — the gold standard for diagnosis. This reveals the tumor subtype and grade (I, II, or III). Cost: $250–$600 including pathology fees.
  4. Staging — Imaging & Bloodwork (Visit 2 or 3): Once STS is confirmed, staging determines whether the cancer has spread.
    • Thoracic radiographs (chest X-rays): Three views to check for lung metastasis. Cost: $200–$450.
    • Abdominal ultrasound: Evaluates internal organs for spread. Cost: $350–$600.
    • Complete blood count (CBC) and biochemistry panel: Baseline health assessment. Cost: $120–$250.
    • CT scan or MRI of the tumor site: Critical for surgical planning — reveals the tumor's exact margins and involvement with surrounding structures. Cost: $1,200–$2,500 depending on facility and sedation/anesthesia requirements.
Total Diagnostic Cost Estimate: Expect to spend between $1,800 and $4,500 for a complete diagnostic workup including biopsy and staging. Advanced imaging (CT/MRI) at a specialty center pushes costs toward the higher end. Pet insurance with illness coverage can reimburse 70–90% depending on your policy.

Understanding Tumor Grading: Why It Matters

Histopathology assigns each soft tissue sarcoma a grade that directly predicts behavior and guides treatment:

Soft Tissue Sarcoma Grading System
GradeCharacteristicsMetastasis RateLocal Recurrence Risk
Grade I (Low) Well-differentiated cells, low mitotic index, minimal necrosis Less than 10% 7–13% with surgical excision
Grade II (Intermediate) Moderate differentiation, moderate mitotic activity 10–20% 14–25% with surgical excision
Grade III (High) Poorly differentiated cells, high mitotic index, significant necrosis 25–44% 25–40% with surgical excision alone

The grade is determined by the veterinary pathologist using criteria that include mitotic count (how rapidly cells are dividing), degree of differentiation (how much tumor cells resemble normal tissue), and presence of necrosis (dead tissue within the tumor). Approximately 50–60% of soft tissue sarcomas are Grade I or II at diagnosis, which is favorable news for many dog owners.

Can Canine Soft Tissue Sarcoma Be Treated? Treatment Options Compared

Yes — soft tissue sarcomas are treatable, and many dogs achieve long-term control or even functional cure with appropriate intervention. The primary challenge is local tumor control: these tumors send microscopic "fingers" (pseudopods) into surrounding healthy tissue, making complete removal technically demanding.

  • Low-dose daily oral chemotherapy; fewer side effects than conventional chemo; requires regular blood monitoring
  • Treatment Options for Canine Soft Tissue Sarcoma
    TreatmentBest ForSuccess Rate / OutcomeCost RangeKey Considerations
    Wide Surgical Excision Localized tumors with accessible margins; first-line treatment Median survival 1,000–1,800+ days for Grade I/II with clean margins; local recurrence 7–25% $1,500–$5,000 depending on tumor location and reconstruction needs Requires 2–3 cm lateral margins and one fascial plane deep; limb tumors may require amputation
    Radiation Therapy Incomplete surgical margins; tumors in locations where wide excision is impossible Local control rates 70–85% when combined with surgery; median survival 1,200–1,500 days $4,000–$8,000 for a full course (15–20 fractions) Requires general anesthesia for each session; available at veterinary specialty centers; acute skin reactions common but manageable
    Metronomic Chemotherapy Post-surgery adjunct for Grade II/III tumors; palliative cases May delay recurrence; limited standalone data but promising in combination protocols $150–$400/month (cyclophosphamide + NSAID protocol)
    Conventional Chemotherapy Grade III tumors; known or suspected metastatic disease Doxorubicin-based protocols show 25–40% response rate in high-grade STS; modest survival benefit $3,000–$6,000 for a 6-treatment protocol More effective for round cell tumors than sarcomas; used selectively based on grade and staging results
    Electrochemotherapy (ECT) Superficial or incompletely excised tumors; emerging option Local response rates 60–80% in preliminary studies; limited long-term data $1,500–$3,000 per session Combines electrical pulses with chemotherapy to increase drug uptake in tumor cells; available at select specialty centers
    Palliative / Supportive Care Advanced disease, owners declining aggressive treatment, or poor surgical candidates Focuses on quality of life; survival varies widely (weeks to months) $100–$500/month for pain management and monitoring NSAIDs, gabapentin, tramadol, wound care; quality of life assessments critical

    The Surgery Gold Standard: Wide Margins

    For soft tissue sarcomas, surgical excision with wide margins — removing the visible tumor plus 2–3 cm of healthy-appearing tissue in all directions and one deep fascial plane — is the single most important factor in preventing local recurrence. Studies published in the Journal of the American Veterinary Medical Association consistently show that dogs with histologically confirmed clean margins (no tumor cells at the edges of removed tissue) have significantly longer disease-free intervals than those with incomplete margins.

    This is why pre-surgical CT or MRI imaging is so valuable: it allows the surgeon to plan the excision precisely, increasing the likelihood of achieving clean margins on the first attempt. A second surgery to "clean up" incomplete margins is possible but less ideal and more costly.

    When Amputation Becomes Necessary

    If a soft tissue sarcoma is located on a distal limb and wraps around bone, major blood vessels, or nerves, achieving wide margins without amputation may be impossible. While the prospect of limb amputation is distressing, most dogs — even large breeds — adapt remarkably well to life on three legs. Recovery typically takes 2–4 weeks, and quality of life post-amputation is generally excellent.

    Prognosis & Life Expectancy: What to Realistically Expect

    Prognosis for canine soft tissue sarcoma depends heavily on tumor grade, surgical margin status, and whether metastasis is present at diagnosis. Here's a realistic breakdown:

    Prognosis by Grade and Treatment Approach
    ScenarioMedian Survival Time1-Year Survival2-Year Survival
    Grade I/II — Complete surgical excision (clean margins) 1,500–2,200+ days (many die of unrelated causes) 90–95% 80–90%
    Grade I/II — Incomplete margins + radiation therapy 1,200–1,800 days 85–90% 75–85%
    Grade I/II — Incomplete margins, no further treatment 500–900 days (high local recurrence risk) 70–80% 45–60%
    Grade III — Surgery + chemotherapy/radiation 400–800 days 55–70% 30–50%
    Any grade — Metastasis present at diagnosis 150–400 days 30–50% 10–25%

    The encouraging takeaway: the majority of soft tissue sarcomas are low to intermediate grade, and with appropriate surgical treatment, many dogs live normal lifespans. Metastasis at initial presentation is relatively uncommon — studies suggest fewer than 15% of dogs have detectable metastasis at the time of diagnosis, with the lungs being the most common metastatic site.

    Important caveat: Survival statistics are population medians — individual dogs may do significantly better or worse. Your dog's specific prognosis depends on tumor subtype, location, grade, margin status, and overall health. Your veterinary oncologist is the best source for a personalized prognosis.

    Home Care, Monitoring & Lifestyle Adjustments

    Whether your dog is recovering from surgery, undergoing radiation, or being managed palliatively, home care plays a critical role in outcomes.

    Post-Surgical Recovery (First 2–4 Weeks)

    • Restrict activity: Leash walks only for bathroom breaks; no running, jumping, or roughhousing for 10–14 days minimum. Use a recovery cone or surgical suit to prevent licking.
    • Incision monitoring: Check the incision twice daily for redness, swelling, discharge, or dehiscence (opening). Photograph daily to track healing.
    • Pain management: Administer prescribed medications (typically carprofen or meloxicam + gabapentin or tramadol) on schedule — don't wait for visible pain signs.
    • Follow-up visits: Suture removal at 10–14 days; recheck at 4–6 weeks; then every 3 months for the first year for recurrence monitoring.

    Long-Term Monitoring Protocol

    • Monthly body checks: Run your hands over your dog's entire body — limbs, chest, abdomen, neck — feeling for new lumps. Measure and photograph any existing masses.
    • Chest X-rays every 3–6 months: For dogs with Grade II or III tumors, periodic thoracic radiographs catch lung metastasis early when intervention may still help.
    • Weight management: Maintain a lean body condition score (BCS 4–5 on a 9-point scale). Excess body fat is associated with increased inflammation and may promote tumor progression.
    • Nutrition: Feed a complete-and-balanced diet meeting AAFCO standards. Some veterinary oncologists recommend diets higher in omega-3 fatty acids and moderate in protein, but consult your veterinarian before making significant dietary changes.

    Quality of Life Assessments

    For dogs managed palliatively or in advanced disease, regular quality of life assessments are essential. The HHHHHMM Scale (Hurt, Hunger, Hydration, Hygiene, Happiness, Mobility, More good days than bad) is a validated tool many veterinarians recommend. Score each category 1–5 weekly; when bad days consistently outnumber good days, it may be time to discuss end-of-life decisions with your veterinarian.

    How Much Does Canine Soft Tissue Sarcoma Treatment Cost?

    Cancer treatment costs are a legitimate concern for most dog owners. Here's a realistic breakdown based on 2025–2026 veterinary pricing data from general practice and specialty oncology centers:

    Estimated Cost Ranges for STS Diagnosis & Treatment
    ServiceLow EstimateHigh EstimateNotes
    Initial exam + FNA$140$320General practice
    Surgical biopsy + histopathology$250$600Includes pathologist fee
    Staging (X-rays, bloodwork, ultrasound)$670$1,300Varies by tests needed
    CT scan or MRI$1,200$2,500Specialty center pricing
    Wide surgical excision$1,500$5,000Complex reconstructions cost more
    Limb amputation$2,000$4,500Includes hospitalization
    Radiation therapy (full course)$4,000$8,00015–20 treatments
    Chemotherapy (6 treatments)$3,000$6,000Doxorubicin-based protocol
    Metronomic chemotherapy (monthly)$150$400Ongoing oral medication
    Post-treatment monitoring (year 1)$600$1,500Rechecks, imaging, bloodwork

    Total estimated cost ranges:

    • Surgery only (best case, clean margins, Grade I): $3,500–$7,500 total including diagnostics
    • Surgery + radiation (incomplete margins): $8,000–$16,000 total
    • Surgery + chemotherapy (Grade III): $7,500–$14,000 total
    • Multimodal aggressive treatment: $12,000–$22,000+
    • Palliative care only: $1,200–$6,000/year

    Pet insurance with comprehensive illness coverage can significantly offset these costs — most plans reimburse 70–90% after deductible. However, pre-existing conditions are universally excluded, making enrollment before a cancer diagnosis essential. If your dog is uninsured, ask your veterinarian about CareCredit, Scratchpay, or local veterinary charitable funds.

    Can Soft Tissue Sarcoma Be Prevented?

    There is no proven method to prevent soft tissue sarcomas in dogs. Unlike some cancers linked to specific causes (such as hemangiosarcoma's breed-genetic component or transitional cell carcinoma's association with certain herbicide exposures), STS arises from diverse tissue types without a single identifiable trigger.

    That said, general cancer risk-reduction strategies apply:

    • Spay/neuter timing: Discuss optimal timing with your veterinarian. Some evidence suggests that early spay/neuter in large breeds may alter cancer risk profiles, though data specific to STS is limited.
    • Weight management: Obesity is a known risk factor for several canine cancers. Maintaining a lean body condition score throughout life reduces systemic inflammation.
    • Minimize toxin exposure: Limit exposure to lawn chemicals, secondhand smoke, and known carcinogens where practical.
    • Regular veterinary wellness exams: Biannual check-ups with full-body palpation catch masses earlier, when treatment is most effective and least costly.
    • Genetic awareness: If you own a predisposed breed (Golden Retriever, Labrador, German Shepherd), maintain heightened vigilance for lumps and discuss cancer screening protocols with your veterinarian.

    When to See the Vet: Red Flag Symptoms

    Seek Veterinary Attention Promptly If You Notice:
    • Any new lump that is firm, fixed to underlying tissue, or growing — regardless of size
    • A previously stable lump that suddenly increases in size, changes shape, or becomes painful
    • A lump that ulcerates, bleeds, or discharges fluid
    • Unexplained lameness lasting more than 48 hours, especially with a palpable mass on the affected limb
    • Rapid weight loss, persistent lethargy, or unexplained appetite decline in conjunction with any mass
    • Difficulty breathing, persistent cough, or exercise intolerance — potential signs of lung metastasis
    • Neurological changes (limb weakness, dragging toes, muscle wasting) near a mass — possible nerve involvement

    Do not adopt a "wait and see" approach with firm, growing masses. Early intervention dramatically improves outcomes and reduces treatment costs. A simple FNA or biopsy can provide answers within days.

    Frequently Asked Questions About Canine Soft Tissue Sarcoma

    What is canine soft tissue sarcoma in dogs?

    Canine soft tissue sarcoma is a group of malignant tumors originating from connective tissues such as fat, muscle, fibrous tissue, nerves, and blood vessels. They typically appear as firm masses under the skin and are classified by grade (I–III) based on how aggressive the cells appear under a microscope. They represent approximately 8–15% of all canine skin and subcutaneous tumors.

    How fast do soft tissue sarcomas grow in dogs?

    Growth rates vary significantly by grade and subtype. Low-grade tumors may grow slowly over months, increasing by just millimeters per week. High-grade tumors can double in size within 2–4 weeks. Any mass that measurably grows over a 2–3 week period warrants veterinary evaluation.

    Is soft tissue sarcoma painful for dogs?

    In early stages, most soft tissue sarcomas are painless — which is partly why they're often detected late. Pain typically develops as the tumor grows large enough to compress nerves, stretch skin, or invade muscle and bone. Advanced tumors that ulcerate can become quite painful. Post-surgical pain is manageable with standard veterinary analgesics.

    Can soft tissue sarcoma be cured?

    Many low-grade and intermediate-grade soft tissue sarcomas are effectively cured with complete surgical excision. "Cure" in oncology typically means no evidence of disease for the dog's remaining lifespan. Dogs with Grade I tumors and clean surgical margins have an excellent chance of cure. Higher-grade tumors carry greater recurrence and metastasis risk, making long-term cure less certain but still achievable in some cases.

    How much does treatment cost?

    Total costs range from approximately $3,500 for surgery-only treatment of a straightforward case to $22,000+ for complex multimodal treatment involving surgery, radiation, and chemotherapy. Diagnostics alone typically cost $1,800–$4,500. Pet insurance, CareCredit, and veterinary charitable organizations can help manage costs.

    What is the life expectancy of a dog with soft tissue sarcoma?

    Life expectancy varies widely. Dogs with low-grade tumors and clean surgical margins often live normal lifespans (median survival exceeding 1,500 days). Dogs with high-grade tumors or metastatic disease may have survival times of 150–800 days depending on treatment. The majority of STS cases fall in the low-to-intermediate grade category with favorable outcomes.

    Which breeds are most prone to soft tissue sarcoma?

    Large and giant breeds are overrepresented, particularly Golden Retrievers, Labrador Retrievers, German Shepherds, Boxers, and Flat-Coated Retrievers. However, soft tissue sarcomas occur across all breeds and in mixed-breed dogs. Dogs over 40 lb (18 kg) and over 8 years of age carry the highest general risk.

    Should I see a veterinary oncologist?

    If your dog is diagnosed with a Grade II (with incomplete margins) or Grade III soft tissue sarcoma, or if the tumor is in a surgically challenging location (near the spine, on a limb where wide margins are difficult), referral to a board-certified veterinary oncologist (DACVIM-Oncology) is strongly recommended. Your primary veterinarian can coordinate this referral.

    Written by

    Beth Carrasco

    All our authors care for dogs every day — read more of their work on the authors page.